Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapyNadezda Gracheva, Nicholas P. van der Meulen|EJNMMI Radiopharmacy and Chemistry|2019Cited by 107